Literature DB >> 20965525

Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.

Faidon Magkos, Christos S Mantzoros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20965525      PMCID： PMC3036773          DOI： 10.1016/j.metabol.2010.09.011

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  44 in total

1.  Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children.

Authors:  Alessandra Viganò; Stefano Mora; Corrado Testolin; Sabrina Beccio; Laura Schneider; Dorella Bricalli; Angelo Vanzulli; Paola Manzoni; Paolo Brambilla
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

2.  Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.

Authors:  Bella Kalderon; Nina Mayorek; Limor Ben-Yaacov; Jacob Bar-Tana
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-12-17       Impact factor: 4.310

3.  Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.

Authors:  Jennifer H Lee; Jean L Chan; Epaminondas Sourlas; Vassilios Raptopoulos; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

4.  Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.

Authors:  Marion A M den Boer; Jimmy F P Berbée; Peter Reiss; Marc van der Valk; Peter J Voshol; Folkert Kuipers; Louis M Havekes; Patrick C N Rensen; Johannes A Romijn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-03       Impact factor: 8.311

5.  Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood.

Authors:  David Dimock; Vijaya Thomas; Anna Cushing; Julia B Purdy; Carol Worrell; Jeffrey B Kopp; Rohan Hazra; Colleen Hadigan
Journal:  Metabolism       Date:  2010-10-13       Impact factor: 8.694

6.  Metabolic and hepatobiliary side effects of antiretroviral therapy (ART).

Authors:  Daniel M Lugassy; Brenna M Farmer; Lewis S Nelson
Journal:  Emerg Med Clin North Am       Date:  2010-05       Impact factor: 2.264

7.  Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis.

Authors:  Rosalind J Carter; Jeffrey Wiener; Elaine J Abrams; John Farley; Steven Nesheim; Paul Palumbo; Marc Bulterys
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

8.  Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

Authors:  Grace M Aldrovandi; Jane C Lindsey; Denise L Jacobson; Amanda Zadzilka; Elizabeth Sheeran; Jack Moye; Peggy Borum; William A Meyer; Dana S Hardin; Kathleen Mulligan
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

9.  Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.

Authors:  Michael P Dubé; Lauren Komarow; Kathleen Mulligan; Steven K Grinspoon; Robert A Parker; Gregory K Robbins; Ronenn Roubenoff; Pablo Tebas
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

10.  Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy.

Authors:  Birgitte Lindegaard; Christian Frøsig; Anne Marie W Petersen; Peter Plomgaard; Susanne Ditlevsen; Bettina Mittendorfer; Gerrit Van Hall; Jørgen F P Wojtaszewski; Bente K Pedersen
Journal:  Diabetes       Date:  2007-06-29       Impact factor: 9.461
View more
  12 in total

1.  Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

Authors:  S B Bahrami; C Tolg; T Peart; C Symonette; M Veiseh; J U Umoh; D W Holdsworth; J B McCarthy; L G Luyt; M J Bissell; A Yazdani; E A Turley
Journal:  Integr Biol (Camb)       Date:  2017-02-20       Impact factor: 2.192

Review 2.  Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.

Authors:  Absalon D Gutierrez; Ashok Balasubramanyam
Journal:  Endocrine       Date:  2011-12-02       Impact factor: 3.633

Review 3.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

4.  Adiponectin administration prevents weight gain and glycemic profile changes in diet-induced obese immune deficient Rag1-/- mice lacking mature lymphocytes.

Authors:  Xiaowen Liu; Nikolaos Perakakis; Huizhi Gong; John P Chamberland; Mary T Brinkoetter; Ole-Petter R Hamnvik; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-09-22       Impact factor: 8.694

Review 5.  Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.

Authors:  Christina-Maria Flessa; Ioannis Kyrou; Narjes Nasiri-Ansari; Gregory Kaltsas; Athanasios G Papavassiliou; Eva Kassi; Harpal S Randeva
Journal:  Curr Obes Rep       Date:  2021-03-22

6.  Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.

Authors:  Catherine N Vu; Raul Ruiz-Esponda; Eric Yang; Evelyn Chang; Baiba Gillard; Henry J Pownall; Ron C Hoogeveen; Ivonne Coraza; Ashok Balasubramanyam
Journal:  Metabolism       Date:  2013-03-19       Impact factor: 8.694

Review 7.  Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.

Authors:  Ovidiu Galescu; Amrit Bhangoo; Svetlana Ten
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

8.  Leptin in relation to the lipodystrophy-associated metabolic syndrome.

Authors:  Christos S Mantzoros
Journal:  Diabetes Metab J       Date:  2012-06-14       Impact factor: 5.376

9.  Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.

Authors:  Catherine N Le; Todd Hulgan; Chi-Hong Tseng; Ginger L Milne; Jordan E Lake
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.240

Review 10.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.